在艾滋病毒,糖尿病和营养补充研究中的坚持定义,测量方法和心理测量属性:范围审查
Julia Burleson1, Daryl E Stephens1, Rajiv N Rimal1
1Department of Health, Behavior and Society, Bloomberg School of Public Health, Johns Hopkins University, Baltimore, MD, USA.
Patient preference and adherence
|February 17, 2025
概括
由于各种定义和方法,准确测量药物坚持仍然具有挑战性. 本次审查强调了在慢性疾病研究中需要多种测量和报告心理测量属性的必要性,以获得可靠的坚持数据.
科学领域:
- 卫生科学 卫生科学 卫生科学
- 临床研究 临床研究
- 药理学 药理学是指药理学的学科.
背景情况:
- 准确测量药物坚持对于有效的慢性疾病管理至关重要.
- 由于缺乏黄金标准的依从度,导致研究得出不同的结论.
- 坚持测量的变化会影响患者的护理和研究结果.
研究的目的:
- 确定艾滋病毒,糖尿病和营养补充剂的坚持测量模式.
- 探索坚持定义,测量工具和心理测量属性的变化.
- 评估国家收入对坚持度测量三角化的影响.
主要方法:
- 进行了2012年1月至2022年1月期间发表的研究范围审查.
- 在PubMed,Scopus和PsycINFO中搜索了关于坚持测量心理测量属性的研究.
- 包括88项关于艾滋病毒,糖尿病或营养补充剂药物的坚持报告的研究.
主要成果:
- 8项莫里斯基药物坚持度表 (MMAS-8) 是最常见的自我报告指标.
- 坚持的定义各不相同,分为数值,二分法,排序顺序或未定义.
- 超过一半的研究报告了有效性和可靠性 (52%),而其他研究报告只有一个或没有.
结论:
- 准确可靠地测量坚持性在艾滋病毒,糖尿病和营养补充剂研究中提出了持续的挑战.
- 研究人员应该使用多种措施和方式报告遵守,提供数值数据,并包括全面的心理测量属性.
- 标准化遵守测量报告对于推进患者护理和研究完整性至关重要.
相关概念视频
01:15Bioavailability Study Design: Healthy Subjects Versus Patients
Bioavailability studies are essential for evaluating a drug's therapeutic efficacy and understanding its absorption patterns under various physiological conditions. Conducting such studies on target patient populations provides more relevant data by simulating real-world disease states. However, practical challenges often necessitate the use of young, healthy adult volunteers as study subjects.Patients may exhibit altered drug absorption patterns due to the effects of the disease itself,...
01:20Measurement of Bioavailability: Pharmacodynamic Methods
Pharmacodynamic methods provide insights into a drug's effects on physiological processes over time and play a crucial role in understanding bioavailability and therapeutic efficacy. These methods can be broadly classified into acute pharmacological and therapeutic response approaches, each with distinct mechanisms and applications.The acute pharmacological response method directly correlates a drug's physiological effects, such as ECG or pupil diameter changes, to its time course in the body.
01:29Therapeutic Drug Monitoring: Affecting Factors
Therapeutic Drug Monitoring (TDM) is the clinical practice of measuring specific drug levels in a patient's blood or body tissues to manage and optimize therapy. TDM is crucial for drugs with narrow therapeutic windows, like warfarin and phenytoin, where incorrect doses can lead to treatment failure or severe side effects. This monitoring ensures the dosage administered is within a safe and effective range. The factors affecting therapeutic drug monitoring include:Patient-Specific Factors:a.
01:25Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis
Type 2 diabetes mellitus develops gradually and is often asymptomatic in early stages.Clinical ManifestationsWhen symptoms appear, they include fatigue, blurred vision, pruritus, delayed wound healing, and recurrent infections, particularly candidal infections. Peripheral neuropathy may present as numbness or tingling in the extremities. Classic hyperglycemia symptoms—polyuria, polydipsia, and polyphagia—are less common. Most patients are overweight and frequently have associated hypertension...
01:29Hyperglycemia
Hyperglycemia is an abnormally high blood glucose level. It is diagnosed by fasting glucose ≥126 mg/dL, 2-hour oral glucose tolerance test (or OGTT) ≥200 mg/dL, random glucose ≥200 mg/dL with symptoms, or HbA1c ≥6.5%. However, HbA1c results may be unreliable in certain conditions, such as anemia or hemoglobinopathies, and the diagnosis should be confirmed unless classic symptoms are present. Postprandial hyperglycemia is typically considered significant when glucose levels exceed 180 mg/dL two...